In case you missed it: News bites for the week.
Bottom-line profit falls on bull team revaluation.
The money is earmarked to support an increased demand for the bladder cancer tests.
UPDATED: Share price lifts on debut.
Trading performance gives confidence cash can be paid out to shareholders.
Fees criticised by the banking Royal Commission are still charged in NZ.
Providers say union calls for mandatory minimum staff-to-resident ratios won't work.
UPDATED: The stock tops Sharesies highest annual return and price change investment filters.
New strategy aimed at making company a ‘sharemarket darling’ once more, CEO says
Another regulatory run-in for China-focused stockbroker.
